Takeda appoints Ashok Bhattacharya to target Indian market & realise larger goals

Views: 4.0K

Effecting a major leadership change at its India operations, Japan’s largest drug maker Takeda Pharmaceutical Co. has replaced Aman Bajaaj, the outgoing General Manager, with Ashok Bhattacharya, the current head of commercial operations.

Takeda2Overall, it seems the change has been undertaken to strengthen Takeda’s position in emerging markets, especially India. Globally, Takeda reportedly ranks 18th among the 20 large pharma companies worldwide. Lately, it has witnessed many roadblocks, such as shrinking Japanese market and flagging pipeline of drugs, when it comes to releasing the larger goal of becoming the world leader oncology and gastrointestinal treatments and gain control of new drugs the company can develop to sell worldwide. This change is one of the strategies to spread its root across the Indian market. With rival global pharma companies making profits by launching new medicine post brokering multi-billion dollars acquisitions, Takeda now aims at moving ahead of its competitors.


Christophe Weber, the Frenchman who last year took over as Takeda’s first foreign CEO Christophe Weber has been designing innovative business strategies to drive  Takeda towards teh goal of becoming the global leader in pharma sector

Christophe Weber, who is Takeda’s first foreign CEO, has been designing innovative business strategies to drive Takeda towards the goal of becoming the global leader in pharma sector


  • In 2013, it had received regulatory approval from the Indian drug authorities for its anti-diabetes drug alogliptin, but held back the launch despite a robust growth seen in the product segment.
  • Wants to capitalise on the growth opportunities in India.
  • With the appointment of Christophe Weber as CEO in 2015, who is Takeda’s first non-Japanese CEO, the company is trying to revive growth by focusing on oncology, gastrointestinal meds and emerging markets. Emerging markets in 2014 provided a 10 per cent boost, with double-digit growth in China and Russia.



  1. online business

    April 17, 2018 at 3:43 pm

    I happen to be writing to let you be aware of what a amazing discovery our girl undergone visiting your site. She picked up plenty of things, not to mention what it’s like to have an ideal giving heart to make other individuals smoothly fully grasp some complicated issues. You really surpassed my expectations. Thank you for distributing these insightful, safe, revealing and even fun tips about your topic to Sandra.

  2. office gadgets

    April 19, 2018 at 8:34 pm

    As a Newbie, I am always searching online for articles that can help me. Thank you

  3. Real Estate

    April 19, 2018 at 8:38 pm

    You made some decent points there. I did a search on the issue and found most guys will agree with your site.

  4. business magazine

    April 19, 2018 at 8:39 pm

    Great goods from you, man. I have understand your stuff previous to and you’re just extremely magnificent. I really like what you have acquired here, really like what you are stating and the way in which you say it. You make it entertaining and you still take care of to keep it smart. I can’t wait to read much more from you. This is actually a great site.

  5. I really like and appreciate your blog post.Thanks Again. Really Great.

  6. depforce plus rx

    April 20, 2018 at 9:02 pm

    Valuabke info. Fortunatte mee I foound youjr webb sute
    bby accident, aand I amm surprised whhy thos twistt oof fate didn’t camee
    aboujt earlier! I bookmkarked it.

  7. selling websites

    April 21, 2018 at 12:24 am

    Very neat article post.Much thanks again. Great.

Leave a Reply

Your email address will not be published.

Most Popular





Get Heard Portal


eHealth Event Report



To Top